Vaxcyte Inc (PCVX)
Who owns Vaxcyte Inc (PCVX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.6% of the shares are freely tradable; institutional investors hold 114.6%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 11.48 | 16,575,875 | +23.8 | 03/31/2026 |
| FMR Inc | 11.42 | 16,492,861 | +19.2 | 03/31/2026 |
| Vanguard Group Inc | 8.44 | 12,193,986 | -1.0 | 12/31/2025 |
| T. Rowe Price Investment Management,Inc. | 8.40 | 12,126,017 | -32.6 | 03/31/2026 |
| RA Capital Management, LLC | 7.95 | 11,474,599 | +7.0 | 03/31/2026 |
| BlackRock Inc | 7.60 | 10,971,816 | +7.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.35 | 6,279,545 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.34 | 6,266,701 | +0.0 | 03/31/2026 |
| Wellington Management Company LLP | 3.89 | 5,614,597 | -5.9 | 03/31/2026 |
| Paradigm Biocapital Advisors LP | 3.32 | 4,793,020 | +17.8 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Sell | 378 | 55.91 | 21,135 |
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Sell | 622 | 55.54 | 34,546 |
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Sell | 244 | 55.96 | 13,655 |
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Sell | 756 | 55.52 | 41,970 |
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Sell | 4,415 | 55.93 | 246,935 |
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Sell | 11,783 | 55.52 | 654,133 |
| 27. Jul 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | Other | 16,198 | 2.03 | 32,882 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.